entertainment -WSS

entertainment

author：fashion 2025-09-27 17:02:51 - browse：7

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Will the FTC rein in IQVIA's health data empire?

entertainment

WSS

Teachers share how revamped forgiveness program helped with their student loans

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Democrats decry new health bill for going easy on private equity

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Teachers share how revamped forgiveness program helped with their student loans

knowledge

entertainment

focus

Medicare details structure of new drug price negotiation program

Roche’s Alnylam deal shows drug firms interested in heart drugs

DIEP, the 'gold standard' of breast reconstruction, is under threat

Wisconsin governor employs partial veto to fund schools for 4 centuries

Tori Bowie and the unacceptable rates of Black maternal death

Eisai exec who led development of Alzheimer’s drug to retire

Walensky prepares to leave CDC — and Congress — behind

Biden targets hefty hospital 'facility fees' that often surprise patients

Trump demands the U.S. pay no more for drugs than other countries … again

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

hotspot

The haunting brain science of long Covid

Judge agrees to delay next hearing in Trump classified documents case

Former reverend arrested for allegedly killing 8

Device maker Teleflex to acquire urology company for $600M

UHS says company favors patients whose insurance pays more

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

entertainment

focus

entertainment

Wikipedia